Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1321 Inhibitors

Olr1321 inhibitors are a distinct class of chemical compounds that are specifically designed to target and inhibit the Olr1321 receptor, a member of the olfactory receptor family within the G protein-coupled receptor (GPCR) superfamily. These receptors play a crucial role in the olfactory system, where they are responsible for detecting odorant molecules and initiating the signaling pathways that ultimately lead to the perception of smell. Olr1321 inhibitors function by binding to the receptor's active site, where natural odorant molecules would typically bind, or by interacting with allosteric sites that can modulate the receptor's activity. This binding effectively blocks the receptor from undergoing the conformational changes necessary to trigger intracellular signaling pathways, thereby preventing the receptor from transmitting olfactory signals. The design and development of Olr1321 inhibitors often rely on detailed structural studies of the receptor, using advanced techniques such as X-ray crystallography, molecular dynamics simulations, and cryo-electron microscopy. These studies provide crucial insights into the receptor's binding pockets and other key regions, enabling the creation of inhibitors that are both highly specific and effective in modulating the activity of the Olr1321 receptor.

Chemically, Olr1321 inhibitors encompass a wide range of molecular structures, reflecting the diverse approaches used in their design and synthesis. These inhibitors may be small, lipophilic molecules that easily cross cellular membranes to reach their target receptors, or they may be larger, more complex structures that require sophisticated synthetic methods to optimize their binding affinity and specificity. The synthesis of Olr1321 inhibitors typically involves multiple steps of organic chemistry, including the strategic construction of molecular frameworks and the incorporation of functional groups that enhance the compound's interaction with the receptor. Once synthesized, these inhibitors undergo rigorous characterization using a variety of analytical techniques, such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and high-performance liquid chromatography (HPLC). These methods ensure the structural integrity, purity, and inhibitory potency of the compounds. The study of Olr1321 inhibitors is essential for advancing our understanding of the specific mechanisms by which this olfactory receptor functions and how its activity can be modulated by small molecules. Additionally, this research contributes to the broader field of GPCR biology, offering valuable insights into the molecular processes underlying sensory perception, particularly in the context of olfaction. By deepening our knowledge of how olfactory receptors function and how they can be selectively targeted, scientists can explore new avenues in the study of sensory systems and the intricate biochemical pathways that govern them.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$75.00
$121.00
33
(1)

EGFR inhibitor, may affect signaling pathways intersecting with Olr1321’s function in cell growth and proliferation.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Inhibits multiple receptor tyrosine kinases; could impact pathways like angiogenesis, potentially related to Olr1321.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Targets RAF kinases; might influence cell signaling pathways where Olr1321 is implicated, particularly in cell growth.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual EGFR and HER2 inhibitor, potentially affecting pathways that Olr1321 might be involved in, particularly in cancer cells.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

BCR-ABL and SRC family kinase inhibitor; could modify pathways intersecting with Olr1321’s signaling role.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Inhibits VEGF, PDGF receptors; might influence angiogenesis and growth pathways possibly linked to Olr1321.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Selective EGFR inhibitor; potentially modifies pathways that intersect with Olr1321’s role in cell signaling.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

BCR-ABL tyrosine kinase inhibitor; may influence cell proliferation pathways, possibly intersecting with Olr1321.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

BCR-ABL inhibitor; could impact cell growth and survival pathways, potentially related to Olr1321.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

mTOR inhibitor; potentially alters cell growth and proliferation pathways, which could be linked to Olr1321's function.